Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Octogenarian myeloma patients have more comorbidities, higher Charlson comorbidity scores, lower rates of anti-MM therapy, reduced triplet/quadruplet use, and shorter median OS, while daratumumab positively influenced outcomes.”
Authors: Dor Shpitzer, Yael Cohen, Tamir Shragai, Ori Grossberger, Dana Amsterdam, Anat Reiner-Benaim, Irit Avivi.
More posts featuring Robert Orlowski.
